Month: January 2020
-
Could Higher-Dose and Lower-Dose Insulin Glargine be Equally Effective in Managing Type 1 Diabetes?
In an effort to maintain greater blood-glucose stability throughout the day and minimize highs and lows, some individuals with type 1 diabetes use insulin glargine, which is a once-a-day, long-acting […]
-
Advancements in Characterizing Type 1 Diabetes Heterogeneity
No two people with type 1 diabetes are exactly the same. Each experiences disease progression differently, and the genetic and biological factors that impact this process differ as well. This […]
-
Unraveling the Process of Fetal Pancreas Development
Cell replacement therapy has been at the forefront of type 1 diabetes research for many years. Researchers have explored different ways to reintroduce insulin-producing beta cells into the pancreas or […]
-
Where is the Diabetes Research Connection Heading in 2020?
Our vision is to support innovative scientific inquiry until diabetes is eliminated. Since 2015, we have funded 24 innovative, peer-reviewed type 1 diabetes (T1D) projects and distributed over $1M directly […]
-
2019 Year in Review
With the generosity of our supporters, we funded seven innovative, peer-reviewed type 1 diabetes (T1D) projects, bringing the total to 24, and have several others in the pipeline that will […]
-
Is Cannabis Use Safe for Individuals with Type 1 Diabetes?
Cannabis use has been a hot topic in recent years with more states legalizing recreational use in addition to medicinal use. Just like any drug, cannabis has its risks and […]